Home › Funds › Royce & Associates › VIR
Royce & Associates position in VIR
VIR BIOTECHNOLOGY INC · Health Care
Latest position (Q2 2024)102.90K sh
Reported value held$915.81K
Portfolio Weight0.01%
First reportedQ3 2022
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2022 | 28.31K | $546.00K | New |
| Q4 2022 | 56.90K | $1.44K | Add |
| Q1 2023 | 51.31K | $1.19K | Reduce |
| Q2 2023 | 107.82K | $2.64M | Add |
| Q3 2023 | 102.90K | $964.17K | Reduce |
| Q4 2023 | 102.90K | $1.04M | Hold |
| Q1 2024 | 102.90K | $1.04M | Hold |
| Q2 2024 | 102.90K | $915.81K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding VIR
- BlackRock Inc 20.68M sh · $210.71M · Q2 2026
- Vanguard Group 12.55M sh · $75.67M · Q4 2025
- Point72 Asset Management 5.67M sh · $57.74M · Q2 2026
- Geode Capital Management 3.35M sh · $34.12M · Q2 2026
- Goldman Sachs Group 2.37M sh · $24.10M · Q2 2026
- Fidelity Management & Research (FMR) 2.32M sh · $23.62M · Q2 2026
- Morgan Stanley 2.21M sh · $22.53M · Q2 2026
- Northern Trust Corp 1.43M sh · $14.59M · Q2 2026
- Charles Schwab Investment Management 1.32M sh · $13.48M · Q2 2026
- Bank of America Corp 1.14M sh · $11.64M · Q2 2026
- Two Sigma Investments 1.11M sh · $11.31M · Q2 2026
- Renaissance Technologies 1.02M sh · $10.36M · Q2 2026